Stock Groups

Bayer wins second straight verdict in a Roundup cancer case -Breaking

[ad_1]

© Reuters. FILE PHOTO: Brand and flags of Bayer AG are pictured outdoors a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Picture

By Tom Hals

(Reuters) – A California jury discovered that Bayer (OTC:)’s Roundup weedkiller was not the reason for a girl’s non-Hodgkin’s lymphoma, Bayer mentioned on Thursday, delivering the chemical big its second trial victory over claims the favored herbicide causes most cancers.

The jury in San Bernardino County discovered that Donnetta Stephens’ most cancers was not brought on by her publicity between 1985 and 2017 to Roundup and its lively ingredient glyphosate.

She sued the corporate for negligence and failing to warn her of the risks of Roundup.

“Regardless of everybody’s greatest efforts, it was unattainable to attempt a coherent case by way of Zoom with our schedule,” mentioned Fletch Trammell, Stephens’ legal professional. “We plan to enchantment and stay up for making an attempt the case once more in additional favorable circumstances.”

Trammell famous related circumstances usually took weeks to try to the Stephens case took greater than 4 months as a result of technical issues and lengthy breaks.

Bayer mentioned the decision was in step with the proof.

The Stephens case is the fifth over Roundup to go to a trial verdict.

Plaintiffs have been awarded tens of tens of millions of {dollars} within the first three however Bayer received its first favorable trial final result on Oct. 5, which lifted the corporate’s inventory value.

The corporate mentioned in Could it could be extra selective in settling circumstances and had mentioned Stephens settlement calls for have been unreasonable.

Roundup-related lawsuits have dogged the corporate because it acquired the top-selling model as a part of its $63 billion buy of agricultural seeds and pesticides maker Monsanto (NYSE:) in 2018.

The corporate has spent billions of {dollars} to settle round 96,000 Roundup circumstances of about 125,000.

Bayer remains to be pursuing appeals in two of the three verdicts it misplaced, together with one the corporate hopes shall be thought of by the U.S. Supreme Courtroom, the place a ruling for Bayer may successfully finish the Roundup circumstances.

Disclaimer: Fusion Media want to remind you that the info contained on this web site will not be essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs should not supplied by exchanges however slightly by market makers, and so costs is probably not correct and will differ from the precise market value, which means costs are indicative and never applicable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any accountability for any buying and selling losses you would possibly incur because of utilizing this knowledge.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury because of reliance on the data together with knowledge, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is without doubt one of the riskiest funding kinds attainable.

[ad_2]